Clinical trial

Proton Radiotherapy Versus Radiofrequency Ablation for Patients With Medium or…

NCT02640924 · Chang Gung Memorial Hospital, Other · Unknown status

Key facts

NCT number NCT02640924
Title Proton Radiotherapy Versus Radiofrequency Ablation for Patients With Medium or Large Hepatocellular Carcinoma
Official title Proton Beam Radiotherapy Versus Switching Control Radiofrequency Ablation for Patients With Medium (>3, ≦5 cm) or Large (>5, ≦7cm) Treatment-naive Hepatocellular Carcinoma
Lead sponsor Chang Gung Memorial Hospital, Other
Status Unknown status
Phase Phase 3
Study type Interventional
Conditions Carcinoma, Hepatocellular
Intervention type Procedure, Radiation
Interventions Proton radiotherapy, Radiofrequency Ablation
Enrollment 166
Start date Jan 1, 2016
Primary completion Dec 1, 2018
Completion Dec 1, 2021
First posted Dec 29, 2015
Last update posted Mar 21, 2016
Countries Taiwan

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies